The impact of contouring uncertainty on rectal 3D dose-volume data: Results of a dummy run in a multicenter trial (AIROPROS01-02)

被引:64
作者
Foppiano, F
Fiorino, C
Frezza, G
Greco, C
Valdagni, R
机构
[1] Natl Inst Canc Res, Dept Med Phys, I-16132 Genoa, Italy
[2] HS Raffaele, Dept Med Phys, Milan, Italy
[3] H Bellaria, Dept Radiotherapy, Bologna, Italy
[4] European Inst Oncol, Dept Radiotherapy, Milan, Italy
[5] Casa Cura PioX, Dept Radiotherapy, Milan, Italy
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 57卷 / 02期
关键词
conformal radiotherapy; prostate; rectal toxicity; dummy run; NTCP;
D O I
10.1016/S0360-3016(03)00659-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To estimate the impact of the uncertainty in contouring the rectum on rectal dose-volume parameters and normal tissue complication probability (NTCP) in a prospective (AIROPROS01-02) investigation about rectal toxicity. Methods and Materials: The participants in a prospective trial (18 observers) were asked to draw the external contour of the rectum of 4 sample patients (3 patients undergoing radical conformal radiotherapy, 1 patient undergoing post-prostatectomy) on CT images (0.5 cm spacing) using a 3D treatment planning system. A previously accepted definition of cranial and caudal borders of the rectum was applied. For each patient, four-and six-field 3D-conformal techniques (70-76 Gy, ICRU dose) were planned and DVH/dose statistics of the rectum were calculated. The impact of interobserver variability on rectal volume, cranial and caudal borders, mean, maximum, and median rectal dose, percentage of rectum receiving more than 40, 45, 50, 55, 60, 65, 70, and 75 Gy (V-40-V-75.), and NTCP were investigated. Results: Concerning DVHs, 9/18 observers tended to have some systematic deviation. However, deviations from the mean values greater than 5% were found only in 1/9 because of a systematic discrepancy in the caudal limit assessment (mean deviation from the most frequently chosen slice: 8 mm). No other observers showed a mean deviation in the cranial or the caudal limit definition greater than 5.8 mm. For another observer, it was possible to clearly assess the cause of a relatively large systematic deviation for DVH parameters. In both cases, the observers were contacted to avoid these systematic deviations. When considering the remaining 16/18 observers, the average values of SD for V-40-V-75 ranged between 1% and 4% and were found to be lower (<3%) for the 3 nonoperated patients. The average values of the SD were around 1.5-2 Gy and less than 1.5% for mean/median dose and NTCPs, respectively. Conclusions: Concerning the uncertainty in rectum definition, the collection of rectal dose-volume data in multicenter investigations seems to be feasible after a clear and previously accepted definition of rectum is assessed. However, even with a general agreement on rectum definition, contouring appears to be a quite significant source of uncertainty. A dummy run procedure is useful in identifying possible discrepancies among single observers and in assessing reliable confidence levels on dose-volume constraints because of contouring uncertainty, making the dummy run mandatory in multicenter trials evaluating 3D dose-volume data. (C) 2003 Elsevier Inc.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 27 条
  • [21] Comparison of prostate cancer treatment in two institutions: A quality control study
    Rasch, C
    Remeijer, P
    Koper, PCM
    Meijer, GJ
    Stroom, JC
    Van Herk, M
    Lebesque, JV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04): : 1055 - 1062
  • [22] Sanchez-Nieto B, 2000, Med Dosim, V25, P71, DOI 10.1016/S0958-3947(00)00031-5
  • [23] Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial
    Seddon, B
    Bidmead, M
    Wilson, J
    Khoo, V
    Dearnaley, D
    [J]. RADIOTHERAPY AND ONCOLOGY, 2000, 56 (01) : 73 - 83
  • [24] Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer
    Shu, HKG
    Lee, TT
    Vigneault, E
    Xia, P
    Pickett, B
    Phillips, TL
    Roach, M
    [J]. UROLOGY, 2001, 57 (01) : 102 - 107
  • [25] Late rectal toxicity after conformal radiotherapy of prostate cancer (I):: Multivariate analysis and dose-response
    Skwarchuk, MW
    Jackson, A
    Zelefsky, MJ
    Venkatraman, ES
    Cowen, DM
    Levegrün, S
    Burman, CM
    Fuks, Z
    Leibel, SA
    Ling, CC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (01): : 103 - 113
  • [26] Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial
    Storey, MR
    Pollack, A
    Zagars, G
    Smith, L
    Antolak, J
    Rosen, I
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 635 - 642
  • [27] High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients
    Zelefsky, MJ
    Fuks, Z
    Hunt, M
    Yamada, Y
    Marion, C
    Ling, CC
    Amols, H
    Venkatraman, ES
    Leibel, SA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05): : 1111 - 1116